Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16221951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This databank-based, multicenter study compared all stroke patients with IV tissue plasminogen activator aged > or = 80 years (n = 38) and those < 80 years old (n = 287). Three-month mortality was higher in older patients. Favorable outcome (modified Rankin scale < or = 1) and intracranial hemorrhage (asymptomatic/symptomatic/fatal) were similarly frequent in both groups. Logistic regression showed that stroke severity, time to thrombolysis, glucose level, and history of coronary heart disease independently predicted outcome, whereas age did not.
Medical subject headings
- Stroke
- Thrombolytic Therapy
- Tissue Plasminogen Activator